Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of THEMIS MEDICARE. For a sector overview, read our pharmaceuticals sector report.

Live BSE Quotes Mar 21, 2018 03:37:00 PM
Price (Rs)580.00 Open (Rs) 581.30 High (Rs) 581.30 Low (Rs) 580.00
% Change-1.86 Volume 106 Value (Rs) 61,480 52-Week H/L 798.10 / 380.00
Live NSE Quotes Mar 21, 2018 3:29:55 PM
Price (Rs)575.10 Open (Rs) 591.10 High (Rs) 593.40 Low (Rs) 572.00
% Change-2.69 Volume 1,197 Value (Rs) 699,670 52-Week H/L 799.00 / 387.60
  BSE Sensex | CNX Nifty

Advanced Charts new
Charts by TradingView

THEMIS MEDICARE Share Price Today:

THEMIS MEDICARE last traded price was down 1.9% to Rs 580.0 on the BSE. On the NSE, THEMIS MEDICARE last traded price was down 2.7% to Rs 575.1. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 0.5%. And the benchmark S&P BSE SENSEX was at 33,136.2 (up 0.4%).

Over the last 30 days, the THEMIS MEDICARE share price is up 0.3%. And over the last one year, THEMIS MEDICARE share price is down 1.3%.

Today's Market

Sensex Continues to Trade on a Firm Note; Force Motors Surges 5.8%(01:30 pm)

Indian share markets continued to witness buying momentum in the noon session. Gains were largely seen in realty stocks, consumer durables stocks and software stocks.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

The Best Blue-Chip Stocks to Ride Sensex 100,000(The 5 Minute Wrapup)

Mar 8, 2018

Here are the four criteria by which you can easily identify safe blue-chip stocks to consider investing in this market correction if valuations fall to reasonable levels.

This Phone Call Changed How I Look at Markets...And Will Change You as Well(Smart Contrarian)

Mar 8, 2018

Nifty is down almost 10% from its all-time highs. It may be difficult for retail traders to make money in such markets but not for the institutional traders. Here's how they survive and thrive in such difficult times.

India's Demographic Dividend is Collapsing(Vivek Kaul's Diary)

Mar 19, 2018

The Indian Railways recently received 1.5 crore applications for 90,000 vacancies.

One Private Bank Trounces All Public-Sector Banks(Chart Of The Day)

Mar 12, 2018

The market capitalisation of private sector lender HDFC Bank now exceeds the market capitalisation of all public-sector banks combined.

3 Things That Your Robo-Advisor Will Never Tell You(Outside View)

Mar 12, 2018

PersonalFN explains the three things robo advisory platforms don't tell you.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in THEMIS MEDICARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks